Merck stock slides as 2025 earnings outlook misses estimates
Merck (MRK) shares drop 8% premarket as 2025 outlook falls short of Wall Street estimates, despite beating Q4 expectations ...
AstraZeneca Sales, Core EPS Seen Rising -- Earnings Preview
CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.
PepsiCo Posts Lower Sales Than Expected for Third Straight Quarter
PepsiCo's fourth-quarter earnings fell short of estimates on Tuesday as sales missed expectations for the third straight quarter.
Centene raises 2025 revenue guidance by $4B while maintaining EPS target
The company reported a Q4 adjusted diluted EPS of $0.80 and full-year 2024 adjusted diluted EPS of $7.17, exceeding prior guidance. Revenue guidance for 2025 was raised by $4B to a range of $158B to ...